EXECUTIVE VIEW-Meda CEO says company could double size in two years

STOCKHOLM, May 7 (Reuters) - Swedish drug maker Meda , a recent takeover target of U.S. rival Mylan Inc , said it was well placed to make large acquisitions of its own after posting first-quarter profits in line with expectations and maintaining its year forecast.

from Reuters: Company News http://ift.tt/1ilQMIA

via IFTTT